These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37228495)

  • 1. Survival and complications after neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for locally advanced gastric cancer: a systematic review and meta-analysis.
    Zhu Y; Chen J; Sun X; Lou Y; Fang M; Zhou F; Zhang L; Xin Y
    Front Oncol; 2023; 13():1177557. PubMed ID: 37228495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy and safety of total neoadjuvant therapy versus neoadjuvant chemoradiotherapy in the treatment of locally advanced rectal cancer: a meta-analysis].
    Zhang YQ; Sun KG; Lu JY; Ma J; Yao N; Qin ZH; Yao YH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun; 25(6):531-538. PubMed ID: 35754218
    [No Abstract]   [Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or the gastroesophageal junction: A meta-analysis based on clinical trials.
    Zhao X; Ren Y; Hu Y; Cui N; Wang X; Cui Y
    PLoS One; 2018; 13(8):e0202185. PubMed ID: 30138325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Total Neoadjuvant Treatment Beneficial for Locally Advanced Rectal Cancer? A Meta-Analysis of Randomized Controlled Trials.
    Wu HQ; Li J; Miao JD; Li JW
    Oncology; 2024; 102(5):399-413. PubMed ID: 37926087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemoradiotherapy for resectable gastric cancer: A meta-analysis.
    Chen J; Guo Y; Fang M; Yuan Y; Zhu Y; Xin Y; Zhang L
    Front Oncol; 2022; 12():927119. PubMed ID: 35992846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
    Kokka F; Bryant A; Brockbank E; Powell M; Oram D
    Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-angiogenesis agents plus chemoradiotherapy for locally advanced nasopharyngeal cancer: a systematic review and meta-analysis.
    Sun X; Zhu Y; Lou Y; Lu X; Wang B; Yu D; Guo Y; Xin Y
    Eur Arch Otorhinolaryngol; 2024 Aug; 281(8):3929-3941. PubMed ID: 38625559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in locally advanced esophageal cancer: An updated meta-analysis.
    Liang Z; Chen T; Li W; Lai H; Li L; Wu J; Zhang H; Fang C
    Medicine (Baltimore); 2024 Jan; 103(3):e36785. PubMed ID: 38241577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compare clinical efficacy and safety of neoadjuvant therapy and neoadjuvant chemoradiotherapy for locally advanced rectal cancer: Meta-analysis.
    Wang Y; Yang Y; Liu QQ; Wang SZ
    World J Gastrointest Surg; 2024 Jun; 16(6):1845-1856. PubMed ID: 38983334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemoradiotherapy or chemotherapy? A comprehensive systematic review and meta-analysis of the options for neoadjuvant therapy for treating oesophageal cancer.
    Deng HY; Wang WP; Wang YC; Hu WP; Ni PZ; Lin YD; Chen LQ
    Eur J Cardiothorac Surg; 2017 Mar; 51(3):421-431. PubMed ID: 27694253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of neoadjuvant immunotherapy versus routine neoadjuvant therapy for patients with locally advanced esophageal cancer: A systematic review and meta-analysis.
    Qin H; Liu F; Zhang Y; Liang Y; Mi Y; Yu F; Xu H; Li K; Lin C; Li L; Tian Z; Wang L
    Front Immunol; 2023; 14():1108213. PubMed ID: 37033991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of 5-flurouracil-based neoadjuvant chemotherapy in locally-advanced gastric/gastroesophageal cancer: a meta-analysis.
    Ge L; Wang HJ; Yin D; Lei C; Zhu JF; Cai XH; Zhang GQ
    World J Gastroenterol; 2012 Dec; 18(48):7384-93. PubMed ID: 23326149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy for resectable esophageal cancer: a systematic review and meta-analysis.
    Wang M; Dong W; Liu A; Lai T; Zhang B; Sun Q
    Transl Cancer Res; 2024 Jun; 13(6):2735-2750. PubMed ID: 38988921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent chemoradiotherapy followed by adjuvant chemotherapy versus concurrent chemoradiotherapy alone in locally advanced cervical cancer: A systematic review and meta-analysis.
    Liu H; Ma X; Sun C; Wu M; Xu Z; Zhou S; Yao N; Liu S; Qin X; Han Z
    Front Oncol; 2022; 12():997030. PubMed ID: 36568251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma.
    Hu Q; Wang D; Chen Y; Li X; Cao P; Cao D
    Radiat Oncol; 2019 Jul; 14(1):120. PubMed ID: 31291998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical, oncological, and functional outcomes of local and radical resection after neoadjuvant chemotherapy or chemoradiotherapy for early- and mid-stage rectal cancer: a systematic review and meta-analysis.
    Tan S; Ou Y; Huang S; Gao Q
    Int J Colorectal Dis; 2023 May; 38(1):132. PubMed ID: 37193915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    Lin H; Wang L; Zhong X; Zhang X; Shao L; Wu J
    World J Surg Oncol; 2021 May; 19(1):141. PubMed ID: 33952287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant therapy in locally advanced colon cancer: a meta-analysis and systematic review.
    Cheong CK; Nistala KRY; Ng CH; Syn N; Chang HSY; Sundar R; Yang SY; Chong CS
    J Gastrointest Oncol; 2020 Oct; 11(5):847-857. PubMed ID: 33209481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (Neo)adjuvant Chemoradiotherapy is Beneficial to the Long-term Survival of Locally Advanced Esophageal Squamous Cell Carcinoma: A Network Meta-analysis.
    Jin Z; Chen D; Chen M; Wang C; Zhang B; Zhang J; Zhu C; Shen J
    World J Surg; 2022 Jan; 46(1):136-146. PubMed ID: 34482411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does a long interval between neoadjuvant chemoradiotherapy and surgery benefit the clinical outcomes of locally advanced rectal cancer? A systematic review and meta analyses.
    Yu M; Wang DC; Li S; Huang LY; Wei J
    Int J Colorectal Dis; 2022 Apr; 37(4):855-868. PubMed ID: 35279746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.